Core Viewpoint - Haijia Medical (06078) has seen a stock price increase of over 5%, currently at HKD 14.73, with a trading volume of HKD 87.87 million, following the release of its 2025 performance forecast [1] Financial Performance - For the second half of 2025, the company is expected to achieve revenue between RMB 20.1 billion and RMB 20.6 billion, representing a year-on-year decline of 0% to 3% [1] - Adjusted net profit is projected to be approximately RMB 1.88 billion to RMB 2.28 billion, reflecting a year-on-year change of -7% to +13% [1] - Operating cash flow is anticipated to grow by 36% to 53% year-on-year [1] Market Outlook - The company's hospitals are evenly distributed across the country, and revenue growth is expected to stabilize in 2025 [1] - For 2026, the impact of DRGs payment reform on average hospitalization costs is expected to diminish, potentially leading to positive revenue growth [1] Analyst Insights - Citic Securities believes that despite the earnings warning, the decline in performance has likely bottomed out [1] - The second half of 2025 is expected to see a 2% year-on-year revenue decline, with adjusted net profit anticipated to recover by 3%, indicating improving profitability resilience [1] - Key growth drivers for 2026 include expanding non-national health insurance directory revenue, enhancing existing hospital utilization rates, and reducing debt levels to improve operational leverage and restore profit margins [1]

一个个真实的瞬间、一句句真挚的感言，无不彰显着市民对美好生活的向往，也印证着杭州卫生健 康事业坚持"以人民健康为中心"的发展理念。 "2025杭州健康瞬间"征集活动虽已收官，但健康杭州建设的脚步从未停歇。每一条线索、每一个故 事，都成为总结健康杭州建设经验、优化健康服务举措的重要参考。未来，全市卫生健康系统将以此次 活动为契机，聚焦百姓需求，持续推动卫生健康领域服务向更智慧、更便捷、更包容、更有温度的方向 迈进，让更多"健康中国"的建设成果，落细为每位市民可感、可触的日常幸福。 "带孩子去新建的社区卫生服务中心打疫苗，彻底告别了以往排队拥挤、环境嘈杂的困扰，宽敞明 亮的接种大厅、温馨童趣的等候区域，还有医护人员耐心细致的引导，全程下来既舒心又安心。"年轻 妈妈李女士的分享，展现了杭州基层医疗服务的升级蝶变。如今，越来越多标准化、规范化的社区卫生 服务中心遍布杭城各个角落，让市民在家门口就能享受优质、便捷的医疗健康服务，筑牢全民健康"最 后一公里"防线。 医者仁心暖人心，细微之处见真情。征集到的线索中，不少市民将笔触对准了坚守一线的医护工作 者，定格一个个暖心治愈的瞬间。 去年暑假，发着低烧的曾女士走进家附近的 ...

Group 1 - The core viewpoint of the articles highlights the increasing economic cooperation between Guangzhou and APEC member countries, exemplified by the successful launch of the Ho Chi Minh City Metro Line 2 project, which marks Guangzhou Metro Design Institute's first overseas project [1] - Guangzhou has attracted nearly $120 billion in foreign investment from APEC economies, accounting for 82.8% of the city's total foreign investment, and has invested in 2,684 non-financial projects in APEC countries with a total agreement amount of $24.72 billion, representing 81% of the city's total [1] - The "Guangdong Goods Going Global" initiative aims to enhance the visibility and market influence of high-quality Guangdong products, leveraging the APEC meetings in Guangzhou as a promotional opportunity [2] Group 2 - The Guangdong government is actively promoting the export of Guangdong products and services, with over 2,000 enterprises expected to participate in 150 "Yue Trade Global" overseas exhibitions this year [5] - The establishment of a research and sales center for Guangdong-style pre-prepared dishes in New Zealand and the ongoing Guangdong product expos there indicate a growing platform for Guangdong businesses to expand internationally [3] - In Mexico, there is a rising demand for high-end technology and digital capabilities, creating opportunities for Guangdong enterprises to collaborate in sectors like automotive manufacturing and logistics [4] Group 3 - The "融聚APEC 惠享新机遇" investment promotion event aims to attract foreign investment by introducing favorable policies from the central, provincial, and municipal levels [6] - Guangzhou's focus on emerging industries such as hydrogen energy, pharmaceuticals, and biotechnology is expected to attract more foreign enterprises, particularly from South Korea [6] - The Baiyun International Medical and Health City project, a collaboration with Singapore's Perennial Group, represents a significant investment in healthcare infrastructure, with a total investment of 10 billion yuan [7] Group 4 - The Guangzhou Municipal Bureau of Commerce plans to organize over 100 investment promotion activities in major cities of APEC economies, aiming to facilitate better understanding and investment opportunities for foreign enterprises in Guangzhou [8]

央视网消息：全国政协委员傅小云是遵义医科大学附属医院重症医学专家，从事临床医疗工作近30年。履职期间，他多次深入县 级医院调研，深切感受到让优质医疗资源下沉是破解基层群众看病难的关键。今年全国两会召开前夕，傅小云来到贵州省三都水族自 治县人民医院，针对基层医疗人才培养和数字化建设情况进行调研。 2022年到2024年，傅小云被组织选派到三都水族自治县人民医院帮扶。去年全国两会傅小云提出，县级医院的医疗人才培养工 作"要授人以鱼也要授人以渔"，建议通过专家授课、导师制、临床手把手教学实践等多样化培训机制，培养带着"乡土基因"的"白衣 战士"，留下一支带不走的工作队。 三都水族自治县人民医院骨科副主任何先游是傅小云帮扶期间人才引进的专家，这次傅小云来调研还专门找他了解了当下亟待解 决的问题。 听到何先游希望到上级医院进修学习，傅小云表示会把他的想法带回遵义医科大学附属医院，制定一套针对帮扶医院青年骨干的 培训机制。 全国政协委员 傅小云：国家一直强调优质医疗资源下沉，国家还是要从政策导向上帮助他们不断提升。 除了基层医疗人才培养以外，傅小云还格外关注智慧医院建设。这一年来，傅小云在三甲医院、县级医院和村卫生室多方 ...

2025年,山东省立医院菏泽医院(菏泽市立医院)在市委、市政府坚强领导下,在市卫健委精准指导及市直 有关部门大力支持下,以建设高水平国家区域医疗中心为引领,深入实施"一二三四五"发展战略,通过战略 聚焦、资源整合与管理创新,在提升综合医疗服务能力、强化急危重症救治水平、降低患者外转率、减 轻群众就医负担等方面取得显著成效,为鲁西南群众筑牢"家门口"的健康防线,以实干实绩推动区域医疗 服务高质量发展。 战略聚焦精准规划 明晰建设"路线图" 立足医院高质量发展新阶段,山东省立医院菏泽医院(菏泽市立医院)科学研判发展形势,将2025年确定 为"服务能力提升攻坚年"和"医院运营管理年",以系统性规划为国家区域医疗中心建设定方向、明路 径。 技术人才双轮驱动 锻造发展"硬实力" 以诊疗中心建设为引擎,山东省立医院菏泽医院(菏泽市立医院)推动技术、人才、科研核心要素深度融 合,实现从外部借力到内部生能的跨越式发展。 在山东省立医院"团队带团队"深度支持下,医院成功推动心脏搭桥、瓣膜病手术治疗,颅内动脉瘤介入治 疗、神经内镜下病损切除手术和ECMO(体外膜肺氧合)等多项核心技术落地并实现规模化、常态化应 用。一批关键诊疗技 ...

Core Viewpoint - Tongce Medical (600763) experienced a slight decline in stock price, closing at 49.06 yuan, down 1.33% as of February 9, 2026, with a trading volume of 128,800 hands and a total transaction amount of 633 million yuan [1] Financial Performance - For the first three quarters of 2025, Tongce Medical reported a main revenue of 2.29 billion yuan, an increase of 2.56% year-on-year; net profit attributable to shareholders was 514 million yuan, up 3.16% year-on-year; and net profit excluding non-recurring items was 509 million yuan, rising 3.09% year-on-year [3] - In the third quarter of 2025, the company achieved a single-quarter main revenue of 842 million yuan, a year-on-year increase of 2.34%; net profit attributable to shareholders for the quarter was 192 million yuan, up 2.31% year-on-year; and net profit excluding non-recurring items was also 192 million yuan, increasing by 1.85% year-on-year [3] - The company's debt ratio stands at 25.1%, with investment income of 41.22 million yuan and financial expenses of 31.93 million yuan, while the gross profit margin is 41.69% [3] Market Activity - On February 9, 2026, the net outflow of main funds was 24.39 million yuan, accounting for 3.85% of the total transaction amount, while retail investors saw a net inflow of 12.62 million yuan, representing 2.0% of the total transaction amount [1] - The financing data indicates that on the same day, financing purchases amounted to 50.86 million yuan, while financing repayments totaled 62.15 million yuan, resulting in a net repayment of 11.29 million yuan [2] - The stock has received three buy ratings from institutions in the last 90 days [4]

Core Viewpoint - The trend of foreign patients seeking medical treatment in China is rising, driven by factors such as visa-free policies and the appeal of cost-effective healthcare services [1][3]. Group 1: Medical Tourism Trends - The number of international patients visiting China has increased significantly, with a reported 128 million visits in 2025, marking a 73.6% growth over three years [1]. - Popular medical services among foreign patients include dental care, health check-ups, and traditional Chinese medicine [1]. - Social media platforms like TikTok and Xiaohongshu are amplifying the visibility of medical services in China, showcasing cost comparisons that highlight significant savings for patients [1]. Group 2: Factors Driving Medical Migration - Efficiency, pricing, and quality of healthcare are key drivers for patients seeking treatment abroad, particularly from countries with long wait times for non-emergency procedures [3]. - China is attracting patients from lower-income countries due to its affordable healthcare options while also drawing patients from wealthier nations seeking advanced medical treatments [3]. Group 3: Healthcare System Advantages - Chinese medical institutions are responding effectively to the needs of international patients, offering rapid diagnostic services and streamlined treatment processes [4]. - Private hospitals in cities like Shanghai and Kunming are establishing comprehensive care capabilities for cross-border patients, enhancing the overall patient experience [5]. Group 4: Innovations in Medical Treatment - China's pharmaceutical sector is transitioning from generic to innovative drug development, with new treatments like the cancer drug Ivosidenib being available exclusively in China [6]. - The success stories of patients receiving advanced treatments in China are contributing to the country's growing reputation as a medical destination [6]. Group 5: Market Potential and Challenges - Despite the growth potential, China's inbound medical tourism remains limited compared to countries like Malaysia and South Korea, which receive over a million international patients annually [7]. - Regulatory challenges and the need for improved cross-border healthcare standards are significant barriers to the growth of this sector [9]. Group 6: Policy Developments - Shanghai is actively promoting international medical tourism through pilot programs and policy initiatives aimed at enhancing the city's healthcare offerings [7][8]. - The implementation of supportive policies is beginning to show positive results, with hospitals reporting increased numbers of foreign patients [8]. Group 7: Systemic Issues - Challenges such as regulatory discrepancies, payment processing issues, and the limited duration of visa-free stays pose obstacles for patients requiring extensive treatment [10][11]. - The current focus on pure medical treatment lacks the integration of tourism services, which is essential for developing a robust medical tourism ecosystem [11].

Core Viewpoint - The implementation of a unified medical service pricing mechanism in Gansu aims to address the long-standing issues of inconsistent pricing and project naming in healthcare services, enhancing the management of nearly 3,000 medical service price items across the province [1][2]. Group 1: Focus on Children - New nursing guidelines include pricing for "premature infant care" and "newborn care," which will be incorporated into the medical insurance payment system, reimbursed at the standard for Class A projects [2]. - Additional pricing items for children under six years old have been established to incentivize healthcare providers to offer higher quality services to young patients [2]. - The pricing mechanism acknowledges the value of nursing staff's expertise and labor in high-risk premature infant care, reflecting respect for medical professionals [2]. Group 2: Focus on the Elderly - The implementation of the pricing guidelines has significantly improved services for the elderly, introducing fees for home hospital beds, home care services, and palliative care [2]. - These new medical service price items allow elderly individuals with mobility issues to receive professional medical care at home, particularly during end-of-life stages, ensuring comprehensive physical and psychological support [2]. Group 3: Support for Innovation - Adjustments in medical service pricing have facilitated the clinical application of advanced technologies such as invasive brain-machine interface technology and AI-assisted diagnostics [2]. - The introduction of air medical transport projects will enhance the emergency rescue capabilities of hospitals, creating an efficient "air life channel" for the public [2]. Group 4: Overall Impact - The Gansu Provincial Medical Insurance Bureau aims to standardize hospital charges through these pricing adjustments, making healthcare access more convenient and strengthening medical security, ultimately improving the health satisfaction of the populace [3].

Core Insights - The "Four Major Chronic Diseases" collaborative innovation pilot zone (Taizhou Plan) was launched to enhance health management by 2025, focusing on grassroots health services and corporate health initiatives [1] Group 1: Health Management Initiatives - The National Health Commission established a major scientific research project to address key issues in the prevention and treatment of cancer, cardiovascular, respiratory, and metabolic diseases starting in 2023 [1] - The Taizhou Plan was approved in May 2025, making it the only selected regional plan in the Yangtze River Delta, with a project implementation period of four years [1] Group 2: Local Health Service Development - The release of health risk alerts and health action initiatives is part of Taizhou's effort to deepen its "Healthy City" concept and build a comprehensive health service system [1] - The "Health Service Union" was officially established, comprising several local health institutions, aimed at delivering quality medical resources to industrial parks and providing integrated health protection for enterprises and talent [1]

Core Viewpoint - Southbound funds have increased their holdings in Haijia Medical (06078.HK) by 19,400 shares on February 9, indicating a positive sentiment towards the company [1] Group 1: Southbound Fund Activity - In the last 5 trading days, southbound funds have increased their holdings for 4 days, with a total net increase of 807,800 shares [1] - Over the past 20 trading days, there have been 11 days of net reductions, totaling 3,667,800 shares [1] - Currently, southbound funds hold 202 million shares of Haijia Medical, representing 32.72% of the company's issued ordinary shares [1] Group 2: Company Overview - Haijia Medical Holdings Limited is primarily an investment holding company that provides medical services [1] - The company operates through two business segments: the hospital business segment focuses on comprehensive cancer diagnosis and treatment services, including radiotherapy, chemotherapy, surgery, and targeted therapy [1] - The other business segment is involved in various other operations, with the company primarily conducting its business in the domestic market [1]